Le Lézard
Classified in: Health
Subjects: EXE, VET

USAGov: Recognize The Signs of Suicide and Find Help



WASHINGTON, June 7, 2018 /PRNewswire-USNewswire/ -- Suicide is the second leading cause of death in people between the ages of 15 to 34 in the United States, according to a new study from the Centers for Disease Control (CDC). The report revealed an increase in suicides in nearly every state from 1999 through 2016. Suicide is a serious public health issue that affects families and communities across the nation.

USA.gov Logo (PRNewsFoto/USA.gov) (PRNewsfoto/USAGov)

Its causes can be complex and involve many factors, from mental illness and abuse, to social isolation and depression, but relationship problems and substance misuse are also frequent reasons.

Immediate Help

If you or someone you know needs help, contact the National Suicide Prevention Lifeline at 1 800-273-TALK (8255) or through chat available 24/7. You can also text a professional for help with the Crisis Text Line at 741741.

If you believe someone is in immediate danger, do not leave the person alone and call 911. Know and share these resources--it could save a life.

Find help 24/7 in Spanish at 1-888-628-9454.

Be Aware; Listen

Every 13 minutes, someone commits suicide in the U.S. There are ways to identify signs and make an approach if you suspect a friend or loved one is considering suicide

Service Members and Veterans

USAGov is a federal program that guides you to tips and tools in English and in Spanish from hundreds of government agencies, departments, and programs. We make it easier for you to find answers you can trust about government information and services--online, by phone, e-mail or chat, and in print.

SOURCE USAGov


These press releases may also interest you

at 03:00
COVERIS strengthens its executive leadership team with the appointments of Ulf Wienböker and Bernhard Mumelter to executive roles while reorganizing its operating model into three new business units. Following the recent divestments of its Rigid and...

at 03:00
Menarini Ricerche announced today the initiation of the B-PRECISE-01 clinical trial, a multicenter phase Ib study that will evaluate the safety and efficacy of MEN1611 plus trastuzumab with or without fulvestrant. The study will enroll patients with...

at 02:43
IRRAS AB announced today that, as of October 19, the IRRAS management consists of the following groups and persons: Executive Management Team Kleanthis G. Xanthopoulos, Ph.D. President & CEO Fredrik Alpsten CFO and Deputy CEO Will Martin Chief...

at 02:38
InDex Pharmaceuticals Holding AB (publ) today announced the publication of a post-hoc analysis of COLLECT study data. COLLECT was a clinical study of the Toll-like receptor 9 (TLR9) agonist cobitolimod, a first-in-class treatment for patients with...

at 02:30
The Consumer Goods Forum (CGF) is pleased to announce the launch of the Global Health and Wellness Digital Framework, developed in partnership with Capgemini. The aim of the Framework is to provide CGF members and stakeholders with a guide to how...

at 02:12
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF THE EU MARKET ABUSE REGULATION NO.596/2014  Third public listing of an Arix company, three years after LogicBio inception Arix invests $7.0 million (£5.4 million) in the IPO to...




News published on 7 june 2018 at 17:59 and distributed by: